Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Carrasco-Gomez

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Bioorganic & Medicinal Chemistry Letters|July 20, 2014
Identification of pirinixic acid derivatives bearing a 2-aminothiazole moiety combines dual PPARα/γ activation and dual 5-LO/mPGES-1 inhibitionThomas Hanke, Christina Lamers, Roberto Carrasco Gomez, et al.
Journal of Medicinal Chemistry|September 26, 2014
Extending the structure-activity relationship of anthranilic acid derivatives as farnesoid X receptor modulators: development of a highly potent partial farnesoid X receptor agonistDaniel Merk, Christina Lamers, Khalil Ahmad, et al.
Bioorganic & Medicinal Chemistry Letters|October 12, 2014
Vanillin-derived antiproliferative compounds influence Plk1 activityRoberto Carrasco-Gomez, Sarah Keppner-Witter, Martina Hieke, et al.
Bioorganic & Medicinal Chemistry|May 3, 2015
Fragmentation of GW4064 led to a highly potent partial farnesoid X receptor agonist with improved drug-like propertiesDaniel Flesch, Matthias Gabler, Andreas Lill, et al.
Bioorganic & Medicinal Chemistry|April 2, 2014
Anthranilic acid derivatives as novel ligands for farnesoid X receptor (FXR)Daniel Merk, Matthias Gabler, Roberto Carrasco Gomez, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Bioorganic & Medicinal Chemistry Letters|July 20, 2014
Identification of pirinixic acid derivatives bearing a 2-aminothiazole moiety combines dual PPARα/γ activation and dual 5-LO/mPGES-1 inhibitionThomas Hanke, Christina Lamers, Roberto Carrasco Gomez, et al.
Journal of Medicinal Chemistry|September 26, 2014
Extending the structure-activity relationship of anthranilic acid derivatives as farnesoid X receptor modulators: development of a highly potent partial farnesoid X receptor agonistDaniel Merk, Christina Lamers, Khalil Ahmad, et al.
Bioorganic & Medicinal Chemistry Letters|October 12, 2014
Vanillin-derived antiproliferative compounds influence Plk1 activityRoberto Carrasco-Gomez, Sarah Keppner-Witter, Martina Hieke, et al.
Bioorganic & Medicinal Chemistry|May 3, 2015
Fragmentation of GW4064 led to a highly potent partial farnesoid X receptor agonist with improved drug-like propertiesDaniel Flesch, Matthias Gabler, Andreas Lill, et al.
Bioorganic & Medicinal Chemistry|April 2, 2014
Anthranilic acid derivatives as novel ligands for farnesoid X receptor (FXR)Daniel Merk, Matthias Gabler, Roberto Carrasco Gomez, et al.
Pageof 1